Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Unknown 1Suspended 1Recruiting 1Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1Dermatologic 1

Conditions

Stomach Neoplasms 1Stomach Adenocarcinoma 1Rectal Neoplasms 1Mycosis Fungoides 1Lymphoma, T-Cell, Peripheral 1Lymphoma, T-Cell, Cutaneous 1Lymphoma, T-Cell 1Lymphoma, Large B-Cell, Diffuse 1Lymphoma 1Carcinoma, Non-Small-Cell Lung 1

Interventions

Azacitidine 2duvelisib 1brincidofovir 1Vincristine 1Prednisone 1Etoposide 1Drug Therapy 1Doxorubicin 1Cyclophosphamide 1Abatacept 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Suspended × Lymphoma, T-Cell × Drug Therapy × Clear all
NCT05138458 2023-11-13

IMAGINE

Myeloid Therapeutics

Phase 1/2 Suspended
40 enrolled
DermatologicLymphoid

Mycosis Fungoides, Lymphoma, T-Cell, Lymphoma, T-Cell, Cutaneous, Lymphoma, T-Cell, Peripheral

Data powered by HemOnc (CC BY 4.0) Colophon âš¡